Unique Capabilities at PTS

Access to R&D personnel with expertise in:

01 - Post-polymerization modification of polymers by introduction of functional groups for controlled and orthogonal couplings.

Synthesis of different modified linear polymeric architectures based on polyglutamates and PEG
RD_img1

Our methodology allows for the incorporation of various functionalities by “post?polymerization modification”, thereby forming different reactive groups in the side chains of the polymers. This functionalization strategy allows adjustment of the pharmacological properties of each case to the use thereof in drugs or molecular imaging agents with therapeutic and/or diagnostic application.

02 - Taylor-made Polymer-based Drug Delivery Systems for Therapeutic, Imaging or Dermocosmetic applications

RD_img2

Polymer Chemistry: Development of novel biodegradable polymeric carriers with defined architecture (linear, block-copolymers, star polymers). Synthesis and exhaustive characterization:

- To be used for intracellular or extracellular drug delivery of Low Mw drugs, peptides, proteins and siRNAs

- Also molecular diagnostics (probe conjugation)

Bioconjugation Techniques

- Development of ‘New Chemical Entities’ with improved therapeutic value starting from either new discovered or well-known drugs with specific limitations (solubility, pharmacokinetics, etc)

- Rational design of nanoconjugates, mainly focused on the linking chemistry.

- Polymer combination therapy, looking at drug synergism or specific targeting.

03 - Physicochemical characterization of active compounds or complex systems

01- Gel Permeation Chromatography
RD_img3_1

02- Dynamic Light Scattering
RD_img3_2

03- HPLC
RD_img3_3

04- Circular Dichroism
RD_img3_4

05- H-NMR analysis
RD_img3_5

04 - Biological evaluation of nanopharmaceuticals,in vivo & in vitro

01- Endocytosis / Cell trafficking
(Qualitative and Quantitative methods)
RD_img4_1

02- Protein Expression analysis by western blot
RD_img4_2

03- Cell viability/Cytotoxicity
RD_img4_3

04- Cell viability/Cytotoxicity
RD_img4_4

05 - Nucleic Acid Delivery Systems

Existing Biological Barriers for Nucleic Acid Delivery

- Nuclease degradation
- Low half-life
- Negatively charged
- Hydrophilic character
- Difficulties to cross the plasma membrane

RD_img5

PGA-based nucleic-acid-delivery systems are able to bind to nucleic acids, protect the nucleic acids from enzymatic degradation, promote cellular uptake and promote nuclear entry of the pDNA.

Please contact pts@pts-polymers.com to request an estimate.

PTS FACILITIES:

GMP facilities: The facilities have been designed according to GMP standards, required for the manufacture of sterile products (eye drops, injectable, vaccines, cell therapy, gene therapy and tissue engineering, etc.).

Animal facility: Our Animal Facility is registered as Breeding, user and Supplier Center for Experimentation with Animals with no. ES 250 0001 002 and it is made up of qualified and accredited personnel in Laboratory Animal Science.

H1 -NMR: Equipment and knowledge for the identification, quantification and structural determination of all kind of chemical compounds.

Stem Cell Bank; Cytomics; Screening Platform; Confocal Microscopy; Proteomics

facilities_img